Literature DB >> 17280560

Determination of ethane, pentane and isoprene in exhaled air--effects of breath-holding, flow rate and purified air.

M A E Lärstad1, K Torén, B Bake, A-C Olin.   

Abstract

AIM: Exhaled ethane, pentane and isoprene have been proposed as biomarkers of oxidative stress. The objectives were to explore whether ethane, pentane and isoprene are produced within the airways and to explore the effect of different sampling parameters on analyte concentrations.
METHODS: The flow dependency of the analyte concentrations, the concentrations in dead-space and alveolar air after breath-holding and the influence of inhaling purified air on analyte concentrations were investigated. The analytical method involved thermal desorption from sorbent tubes and gas chromatography. The studied group comprised 13 subjects with clinically stable asthma and 14 healthy controls.
RESULTS: Ethane concentrations decreased slightly, but significantly, at higher flow rates in subjects with asthma (P = 0.0063) but not in healthy controls. Pentane levels were increased at higher flow rates both in healthy and asthmatic subjects (P = 0.022 and 0.0063 respectively). Isoprene levels were increased at higher flow rates, but only significantly in healthy subjects (P = 0.0034). After breath-holding, no significant changes in ethane levels were observed. Pentane and isoprene levels increased significantly after 20 s of breath-holding. Inhalation of purified air before exhalation resulted in a substantial decrease in ethane levels, a moderate decrease in pentane levels and an increase in isoprene levels.
CONCLUSION: The major fractions of exhaled ethane, pentane and isoprene seem to be of systemic origin. There was, however, a tendency for ethane to be flow rate dependent in asthmatic subjects, although to a very limited extent, suggesting that small amounts of ethane may be formed in the airways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17280560     DOI: 10.1111/j.1748-1716.2006.01624.x

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  18 in total

1.  Using a chemiresistor-based alkane sensor to distinguish exhaled breaths of lung cancer patients from subjects with no lung cancer.

Authors:  Jiunn-Liang Tan; Zheng-Xin Yong; Chong-Kin Liam
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

2.  Exhaled breath analysis: The new interface between medicine and engineering.

Authors:  Alquam Mashir; Raed A Dweik
Journal:  Adv Powder Technol       Date:  2009-09       Impact factor: 4.833

3.  Ethane and n-pentane in exhaled breath are biomarkers of exposure not effect.

Authors:  Katrine A Gorham; Mads P Sulbaek Andersen; Simone Meinardi; Ralph J Delfino; Norbert Staimer; Thomas Tjoa; F Sherwood Rowland; Donald R Blake
Journal:  Biomarkers       Date:  2009-02       Impact factor: 2.658

4.  Real Time Breath Analysis Using Portable Gas Chromatography for Adult Asthma Phenotypes.

Authors:  Ruchi Sharma; Wenzhe Zang; Menglian Zhou; Nicole Schafer; Lesa A Begley; Yvonne J Huang; Xudong Fan
Journal:  Metabolites       Date:  2021-04-23

Review 5.  Breath tests in respiratory and critical care medicine: from research to practice in current perspectives.

Authors:  Attapon Cheepsattayakorn; Ruangrong Cheepsattayakorn
Journal:  Biomed Res Int       Date:  2013-09-18       Impact factor: 3.411

Review 6.  Advances in electronic-nose technologies for the detection of volatile biomarker metabolites in the human breath.

Authors:  Alphus D Wilson
Journal:  Metabolites       Date:  2015-03-02

Review 7.  Breath analysis as a potential and non-invasive frontier in disease diagnosis: an overview.

Authors:  Jorge Pereira; Priscilla Porto-Figueira; Carina Cavaco; Khushman Taunk; Srikanth Rapole; Rahul Dhakne; Hampapathalu Nagarajaram; José S Câmara
Journal:  Metabolites       Date:  2015-01-09

8.  Breathing Rhythm Variations during Wash-In Do Not Influence Exhaled Volatile Organic Compound Profile Analyzed by an Electronic Nose.

Authors:  Silvano Dragonieri; Vitaliano Nicola Quaranta; Pierluigi Carratù; Teresa Ranieri; Enrico Buonamico; Giovanna Elisiana Carpagnano
Journal:  Molecules       Date:  2021-05-04       Impact factor: 4.411

Review 9.  Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.

Authors:  Kim D G van de Kant; Linda J T M van der Sande; Quirijn Jöbsis; Onno C P van Schayck; Edward Dompeling
Journal:  Respir Res       Date:  2012-12-21

10.  The case in favor of E-cigarettes for tobacco harm reduction.

Authors:  Joel L Nitzkin
Journal:  Int J Environ Res Public Health       Date:  2014-06       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.